Santen DRC AVANTE Study (Phase II) - Assess Efficacy, Safety of Intravitreal Injections of DE-122 in combination with Lucentis® Compared to Lucentis® Monotherapy in Subjects with Wet AMD
Research Grant
Administered By
Ophthalmology
Awarded By
Santen, Ltd.
Start Date
January 1, 2017
End Date
December 15, 2021
Administered By
Ophthalmology
Awarded By
Santen, Ltd.
Start Date
January 1, 2017
End Date
December 15, 2021